MedTrace Logo

Ventripoint Single Ventricle Study

NCT05262907 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 100

Last updated 2025-10-23

No results posted yet for this study

Summary

This study will validate a coordinate-based 3-dimensional echocardiographic technique for the assessment of cardiac size and function in children and young adults with functional single ventricles.

Conditions

  • Congenital Heart Disease
  • Single-ventricle

Interventions

DEVICE

Transthoracic Echocardiogram or Cardiac MRI

Non-invasive imaging of the heart to evaluate structure and function.

DEVICE

Ventripoint Echocardiogram

Non-invasive ultrasound of the heart to evaluate structure and function through 3D imaging.

Sponsors & Collaborators

Principal Investigators

  • Piers Barker, MD · Duke University

Study Design

Allocation
NON_RANDOMIZED
Purpose
DIAGNOSTIC
Masking
NONE
Model
PARALLEL

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-07-08
Primary Completion
2027-08-31
Completion
2027-08-31
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05262907 on ClinicalTrials.gov